Population-based impact of routine infant immunization with pneumococcal conjugate vaccine in the USA

被引:47
作者
Grijalva, Carlos G. [1 ]
Griffin, Marie R. [1 ,2 ,3 ,4 ]
机构
[1] Vanderbilt Univ, Sch Med, Dept Prevent Med, Div Pharmacoepidemiol, Nashville, TN 37212 USA
[2] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA
[3] VA TN Valley Hlth Care Syst, Midsouth Geriatr Res Educ & Clin Ctr, Nashville, TN 37212 USA
[4] VA TN Valley Hlth Care Syst, Clin Res Ctr Excellence, Nashville, TN 37212 USA
基金
美国医疗保健研究与质量局;
关键词
immunization; invasive pneumococcal disease; otitis media; pneumococcal conjugate vaccine; pneumonia; serotypes;
D O I
10.1586/14760584.7.1.83
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In the year 2000, a heptavalent pneumococcal conjugate vaccine (PCV7) was licensed and recommended for routine immunization of infants in the USA. During the following years, a number of studies documented the impact of this immunization program on rates of invasive pneumococcal disease, pneumonia and otitis media. This article aims to summarize current evidence on the population-based impact of this infant immunization program in the USA.
引用
收藏
页码:83 / 95
页数:13
相关论文
共 79 条
[1]  
Addae-Mensah I, 2005, WHO TECH REP SER, V929, P1
[2]  
Anderson Robert N, 2005, Natl Vital Stat Rep, V53, P1
[3]  
[Anonymous], 2000, MMWR Recomm Rep, V49, P1
[4]  
[Anonymous], 1997, MMWR Recomm Rep, V46, P1
[5]  
[Anonymous], 2007, Wkly Epidemiol Rec, V82, P93
[6]  
[Anonymous], NAT IMM SURV
[7]   Trends in otitis media among children in the United States [J].
Auinger, P ;
Lanphear, BP ;
Kalkwarf, HJ ;
Mansour, ME .
PEDIATRICS, 2003, 112 (03) :514-520
[8]   Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children [J].
Black, S ;
Shinefield, H ;
Fireman, B ;
Lewis, E ;
Ray, P ;
Hansen, JR ;
Elvin, L ;
Ensor, KM ;
Hackell, J ;
Siber, G ;
Malinoski, F ;
Madore, D ;
Chang, I ;
Kohberger, R ;
Watson, W ;
Austrian, R ;
Edwards, K .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (03) :187-195
[9]   Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia [J].
Black, SB ;
Shinefield, HR ;
Ling, S ;
Hansen, J ;
Fireman, B ;
Spring, D ;
Noyes, J ;
Lewis, E ;
Ray, P ;
Lee, J ;
Hackell, J .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2002, 21 (09) :810-815
[10]   SEROTYPE DISTRIBUTION OF STREPTOCOCCUS-PNEUMONIAE INFECTIONS AMONG PRESCHOOL-CHILDREN IN THE UNITED-STATES, 1978-1994 - IMPLICATIONS FOR DEVELOPMENT OF A CONJUGATE VACCINE [J].
BUTLER, JC ;
BREIMAN, RF ;
LIPMAN, HB ;
HOFMANN, J ;
FACKLAM, RR .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (04) :885-889